Search hospitals > North Carolina > Greensboro
Headache Wellness Center
Claim this profileGreensboro, North Carolina 27405
Global Leader in Migraine
Conducts research for Headache
Conducts research for Adolescent Health
Conducts research for Pediatric Migraine
Conducts research for Migraine Headaches
27 reported clinical trials
0 medical researchers
Summary
Headache Wellness Center is a medical facility located in Greensboro, North Carolina. This center is recognized for care of Migraine, Headache, Adolescent Health, Pediatric Migraine, Migraine Headaches and other specialties. Headache Wellness Center is involved with conducting 27 clinical trials across 9 conditions. There are 0 research doctors associated with this hospital, such as .Top PIs
Clinical Trials running at Headache Wellness Center
Migraine
Adolescent Health
Pediatric Migraine
Atogepant + Botox
for Chronic Migraine
This trial is testing a new daily pill called atogepant, used along with regular BOTOX treatments, to help prevent migraines. It targets adults who suffer from frequent and severe headaches. The pill works by blocking certain brain signals that trigger migraines. The study will monitor safety, side effects, and effectiveness over several months. Atogepant is a newly approved medication for the prevention of migraine.
Recruiting2 awards Phase 33 criteria
Rimegepant
for Pediatric Migraine
This trial aims to test the safety of rimegepant, a medication for treating migraines. The study focuses on children and adolescents aged 6 to 17 years who experience moderate to severe migraines. Rimegepant works by blocking a protein that triggers migraine pain, helping to alleviate symptoms.
Recruiting2 awards Phase 38 criteria
Ubrogepant
for Migraine
A migraine is a moderate to severe headache typically on one side of the head. A migraine attack is a headache that may be accompanied by throbbing, nausea, vomiting, sensitivity to light and sound, or other symptoms. Menstrual migraine (MM) is defined as migraine attacks that occur within the perimenstrual period (PMP) in at least 2 out of 3 menstrual cycles. The PMP is from 2 days before the onset of menstrual bleeding to 2 days after. This study will assess how safe and effective ubrogepant is in treating menstrual migraine. Adverse Events and change in disease activity will be assessed. Ubrogepant is an investigational drug being developed for short-term prevention of menstrual migraine. Participants will be randomly assigned to one of the 2 groups to receive either ubrogepant or placebo. Around 450 adult female participants with menstrual migraine will be enrolled in approximately 85 sites in the United States and Puerto Rico. Participants will receive oral ubrogepant tablets once daily for 7 consecutive days starting 3 days prior to estimated onset of menses per cycle for 3 PMPs during double-blind period (16 weeks). Eligible participants may continue to receive oral ubrogepant tablets once daily for 7 consecutive days per cycle starting 3 days prior to estimated onset of menses during open-label extension period (52 weeks). There may be higher treatment burden for participants in this trial compared to their standard of care. Participants will collect data daily in electronic diaries and attend regular visits during the study at a hospital or clinic. The effect of the treatment will be checked by medical assessments, blood tests, checking for side effects and completing questionnaires.
Recruiting1 award Phase 33 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Headache Wellness Center?
Headache Wellness Center is a medical facility located in Greensboro, North Carolina. This center is recognized for care of Migraine, Headache, Adolescent Health, Pediatric Migraine, Migraine Headaches and other specialties. Headache Wellness Center is involved with conducting 27 clinical trials across 9 conditions. There are 0 research doctors associated with this hospital, such as .